CCL11 and hepatocellular carcinoma: Clinical investigations by Ng et al. involving 150 liver transplant recipients revealed that elevated post-transplant circulating CCL11 levels significantly correlate with HCC recurrence, suggesting its potential as a recurrence biomarker [72].